- Previous Close
0.0000 - Open
0.1121 - Bid 0.0784 x --
- Ask 0.1031 x --
- Day's Range
0.1121 - 0.1121 - 52 Week Range
0.0599 - 0.1439 - Volume
4,000 - Avg. Volume
6,370 - Market Cap (intraday)
22.148M - Beta (5Y Monthly) 2.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Aug 27, 2024 - Sep 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
www.nugenmd.comRecent News: NGMDF
View More
Performance Overview: NGMDF
Trailing total returns as of 7/19/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NGMDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NGMDF
View MoreValuation Measures
Market Cap
22.11M
Enterprise Value
27.77M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
65.44
Price/Book (mrq)
--
Enterprise Value/Revenue
107.38
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.19%
Return on Equity (ttm)
--
Revenue (ttm)
354.42k
Net Income Avi to Common (ttm)
-9.08M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
394.88k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.51M
Company Insights: NGMDF
NGMDF does not have Company Insights